What is Hyperion Biotechnology?
Founded in 1998 and headquartered in San Antonio, Texas, Hyperion Biotechnology operates as a multifaceted biomedical and clinical research enterprise. The firm distinguishes itself through a diverse service portfolio that spans program management, logistics, medical advisory, and specialized assistance services. As a certified HUB vendor and an 8(m) woman-owned entity, Hyperion occupies a unique niche in the federal contracting ecosystem, particularly in its support of the U.S. Department of Defense.
The company's market position is defined by its ability to streamline complex project lifecycles, thereby improving process efficiency for its clients. By integrating scientific rigor with logistical expertise, Hyperion provides a comprehensive suite of services that address the evolving needs of the public sector, ensuring that mission-critical outcomes are achieved with precision and reliability.
How much funding has Hyperion Biotechnology raised?
Hyperion Biotechnology has raised a total of $680K across 2 funding rounds:
Debt
$350K
Debt
$330K
Debt (2020): $350K with participation from PPP
Debt (2021): $330K led by PPP
Key Investors in Hyperion Biotechnology
PPP
Public-Private Partnership
What's next for Hyperion Biotechnology?
With the recent influx of capital, Hyperion Biotechnology is well-positioned to expand its footprint in the federal and local government sectors. The strategic deployment of these funds will likely focus on enhancing the company's technological infrastructure and broadening its clinical research capabilities to meet the increasing demands of its defense-sector clientele. As the firm continues to navigate the complexities of government procurement, this financial backing provides the necessary runway to pursue larger-scale program management opportunities and further optimize its service delivery models. The focus remains on long-term sustainability and the continued enhancement of operational efficiencies that have become the hallmark of the Hyperion brand.
See full Hyperion Biotechnology company page
